About the journal
Translational Cancer Research is an open-access journal published by AME Publishing Company in Hong Kong SAR China. It is listed in PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- AME Publishing Company
- ISSN
- 2218-676X · 2219-6803
- Country
- Hong Kong SAR China
- Access
- Open access
- Official website
- http://tcr.thepbpc.org
Index listings
- PUBMED · 2012-06-01
- Indexing
- PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
6875
Last recorded publication year
2026
h-index
47
i10-index
867
From OpenAlex open data (CC0).
Editorial & policy3
- Open references deposited at Crossref
- 0%
- ORCID iDs in current deposits
- 0%
- Enrolled in Crossref Similarity Check
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101585958
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
Show all subjects (50)
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- MicroRNA in disease regulation
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatocellular Carcinoma Treatment and Prognosis
- MicroRNA in disease regulation
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- RNA modifications and cancer
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- RNA modifications and cancer
- Cancer Genomics and Diagnostics
- Gastric Cancer Management and Outcomes
- Gastric Cancer Management and Outcomes
- Breast Cancer Treatment Studies
- Cancer, Hypoxia, and Metabolism
- Circular RNAs in diseases
- Circular RNAs in diseases
- Cancer, Hypoxia, and Metabolism
- Radiomics and Machine Learning in Medical Imaging
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- Radiomics and Machine Learning in Medical Imaging
- Esophageal Cancer Research and Treatment
- Esophageal Cancer Research and Treatment
- Glioma Diagnosis and Treatment
- Head and Neck Cancer Studies
- Glioma Diagnosis and Treatment
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Head and Neck Cancer Studies
- Cancer Cells and Metastasis
- Cancer, Lipids, and Metabolism
- Cancer, Lipids, and Metabolism
- Inflammatory Biomarkers in Disease Prognosis
- Immune cells in cancer
- Cancer Cells and Metastasis
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Immune cells in cancer
- Inflammatory Biomarkers in Disease Prognosis
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ